A series of 6-O-(p-substituted phenyl)-modified beta-cyclodextrin derivatives, i.e., 6-O-(4-bromophenyl)-beta-CD (1), 6-O-(4-nitrophenyl)-beta-CD (2), 6-O-(4-formylphenyl)-beta-CD (3), 6-phenylselenyl-6-deoxy-beta-CD (4), and 6-O-(4-hydroxybenzoyl)-beta-CD (5), were synthesized, and their inclusion complexation behavior in aqueous solution and self-assembling behavior in the solid state were comparatively studied by NMR spectroscopy, microcalorimetry, crystallography, and scanning tunneling microscopy. Interestingly, (seleno)ethers 1-4 and ester 5 displayed distinctly different self-assembling behavior in the solid state, affording a successively threading head-to-tail polymeric helical structure for the (seleno)ethers or a mutually penetrating tail-to-tail dimeric columnar channel structure for the ester. Combining the present and previous structures reported for the relevant beta-CD derivatives, we further deduce that the pivot heteroatom, through which the aromatic substituent is tethered to beta-CD, plays a critical role in determining the helix structure, endowing the 2-fold and 4-fold axes to the N/O- and S/Se-pivoted beta-CD aggregates, respectively. This means that one can control the self-assembling orientation, alignment, and helicity in the solid state by finely tuning the pivot atom and the tether length. Further NMR and calorimetric studies on the self-assembling behavior in aqueous solution revealed that the dimerization step is the key to the formation of linear polymeric supramolecular architecture, which is driven by favorable entropic contributions.
Two novel β-cyclodextrin (β-CD) derivatives possessing azobenzene functional groups as a spectral probe,
i.e., mono{6-O-[4-(phenylazo)phenyl]}-β-cyclodextrin (1) and mono{6-O-[4-((4-nitrophenyl)azo)phenyl]}-β-cyclodextrin (2), were synthesized in high yields, and their complexation behaviors with aliphatic alcohols
were evaluated by using UV−vis, circular dichroism, and 1H NMR spectroscopy. The induced circular
dichroism (ICD) and 2D NMR spectroscopy investigations revealed that azobenzene groups attached to the
β-CD rim can be deeply embedded to the β-CD cavity to form the intramolecular inclusion complexes in
10% DMSO aqueous solution. Increasing the ratio of DMSO in solution results in the gradual exclusion of
the azobenzene sidearm from the β-CD cavity. Upon complexation with guest adamantanols, modified β-CD
1 or 2 displays two different binding models, that is, the competitive inclusion model for 2-adamantanol and
the co-inclusion model for 1-adamantanol. These two different models reasonably explain the different binding
behaviors and molecular selectivities of host β-CDs toward guests. Therefore, besides acting as a spectral
probe, azobenzene modified β-CDs can also effectively recognize the size/shape of guest molecules, giving
good molecular selectivity up to 91 for 2-adamantanol/(+)-borneol pair by 1 and the moderate enantioselectivity
(K
-
/K
+ = 2.1) for (−)-/(+)-borneol pair by 2.
A novel supramolecular assembly has been fabricated by the inclusion complexation between organo-selenium bridged bis(β-cyclodextrin)s 2 and calix[4]arene derivative 3 in water-acetonitrile (1:1) mixture solution and characterized by fluorescence, 2D NMR, TEM, SEM, and STM images, showing the nanometer structural wire-shaped aggregates.
[structure: see text] The binding ability and self-assembly behavior of molecular interpenetration by newly synthesized mono[6-O-(4-formyl-phenyl)-beta-cyclodextrin has been investigated, revealing the formation mechanism of modified cyclodextrin from solution aggregation to solid linear polymeric supramolecules.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.